Cargando…

The Development and Validation of Quality of Life Scale for Iraqi Patients with Type 2 Diabetes Mellitus

BACKGROUND AND AIM: The current trend for determining the effectiveness of new treatment or services provided for diabetes mellitus (DM) patients is based on assessing the improvement in both glycemic control and the patient quality of life. Many scales have been developed to assess quality of life...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikhael, Ehab M, Hassali, Mohamed A, Hussain, Saad A, Shawky, Nizar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574754/
https://www.ncbi.nlm.nih.gov/pubmed/33100785
http://dx.doi.org/10.4103/jpbs.JPBS_190_19
_version_ 1783597688949833728
author Mikhael, Ehab M
Hassali, Mohamed A
Hussain, Saad A
Shawky, Nizar
author_facet Mikhael, Ehab M
Hassali, Mohamed A
Hussain, Saad A
Shawky, Nizar
author_sort Mikhael, Ehab M
collection PubMed
description BACKGROUND AND AIM: The current trend for determining the effectiveness of new treatment or services provided for diabetes mellitus (DM) patients is based on assessing the improvement in both glycemic control and the patient quality of life. Many scales have been developed to assess quality of life among DM patients, but unfortunately, no one can be considered as gold standard. Therefore, this study aimed to develop and validate a brief and specific scale to assess quality of life among Iraqi type 2 DM patients. METHODS: An extensive literature review was done using Google-Scholar and PubMed to find out scales that utilized to assess quality of life among DM patients. Four relevant scales, three diabetes specific and one general, were selected. The selected scales were carefully evaluated to find out domains that are commonly used to assess quality of life and then the items within the selected domains were reviewed to choose relevant and comprehensive items for Iraqi type 2 DM patients. Ten items were selected to formulate the quality of life scale for Iraqi DM patients (QOLSID). The content validity of QOLSID was established via an expert panel. For concurrent validity QOLSID was compared to glycosylated hemoglobin (HbA1C). For psychometric evaluation, a cross sectional study for 103 type 2 DM patients was conducted at the National Diabetes Center, Iraq. Test-retest reliability was measured by re-administering QOLSID to 20 patients 2-4 weeks later. RESULTS: The internal consistency of the QOLSID was 0.727. All items had a corrected total-item correlation above 0.2. There was a negative significant correlation between QOLSID score and the HbA1C level (-0.518, P = 0.000). A significant positive correlation was obtained after re-testing (0.967, P = 0.000). CONCLUSION: The QOLSID is a reliable and valid instrument that can be used for assessing quality of life among Iraqi type 2 DM patients.
format Online
Article
Text
id pubmed-7574754
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-75747542020-10-22 The Development and Validation of Quality of Life Scale for Iraqi Patients with Type 2 Diabetes Mellitus Mikhael, Ehab M Hassali, Mohamed A Hussain, Saad A Shawky, Nizar J Pharm Bioallied Sci Original Article BACKGROUND AND AIM: The current trend for determining the effectiveness of new treatment or services provided for diabetes mellitus (DM) patients is based on assessing the improvement in both glycemic control and the patient quality of life. Many scales have been developed to assess quality of life among DM patients, but unfortunately, no one can be considered as gold standard. Therefore, this study aimed to develop and validate a brief and specific scale to assess quality of life among Iraqi type 2 DM patients. METHODS: An extensive literature review was done using Google-Scholar and PubMed to find out scales that utilized to assess quality of life among DM patients. Four relevant scales, three diabetes specific and one general, were selected. The selected scales were carefully evaluated to find out domains that are commonly used to assess quality of life and then the items within the selected domains were reviewed to choose relevant and comprehensive items for Iraqi type 2 DM patients. Ten items were selected to formulate the quality of life scale for Iraqi DM patients (QOLSID). The content validity of QOLSID was established via an expert panel. For concurrent validity QOLSID was compared to glycosylated hemoglobin (HbA1C). For psychometric evaluation, a cross sectional study for 103 type 2 DM patients was conducted at the National Diabetes Center, Iraq. Test-retest reliability was measured by re-administering QOLSID to 20 patients 2-4 weeks later. RESULTS: The internal consistency of the QOLSID was 0.727. All items had a corrected total-item correlation above 0.2. There was a negative significant correlation between QOLSID score and the HbA1C level (-0.518, P = 0.000). A significant positive correlation was obtained after re-testing (0.967, P = 0.000). CONCLUSION: The QOLSID is a reliable and valid instrument that can be used for assessing quality of life among Iraqi type 2 DM patients. Wolters Kluwer - Medknow 2020 2020-07-18 /pmc/articles/PMC7574754/ /pubmed/33100785 http://dx.doi.org/10.4103/jpbs.JPBS_190_19 Text en © 2020 Journal of Pharmacy and Bioallied Sciences http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Mikhael, Ehab M
Hassali, Mohamed A
Hussain, Saad A
Shawky, Nizar
The Development and Validation of Quality of Life Scale for Iraqi Patients with Type 2 Diabetes Mellitus
title The Development and Validation of Quality of Life Scale for Iraqi Patients with Type 2 Diabetes Mellitus
title_full The Development and Validation of Quality of Life Scale for Iraqi Patients with Type 2 Diabetes Mellitus
title_fullStr The Development and Validation of Quality of Life Scale for Iraqi Patients with Type 2 Diabetes Mellitus
title_full_unstemmed The Development and Validation of Quality of Life Scale for Iraqi Patients with Type 2 Diabetes Mellitus
title_short The Development and Validation of Quality of Life Scale for Iraqi Patients with Type 2 Diabetes Mellitus
title_sort development and validation of quality of life scale for iraqi patients with type 2 diabetes mellitus
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574754/
https://www.ncbi.nlm.nih.gov/pubmed/33100785
http://dx.doi.org/10.4103/jpbs.JPBS_190_19
work_keys_str_mv AT mikhaelehabm thedevelopmentandvalidationofqualityoflifescaleforiraqipatientswithtype2diabetesmellitus
AT hassalimohameda thedevelopmentandvalidationofqualityoflifescaleforiraqipatientswithtype2diabetesmellitus
AT hussainsaada thedevelopmentandvalidationofqualityoflifescaleforiraqipatientswithtype2diabetesmellitus
AT shawkynizar thedevelopmentandvalidationofqualityoflifescaleforiraqipatientswithtype2diabetesmellitus
AT mikhaelehabm developmentandvalidationofqualityoflifescaleforiraqipatientswithtype2diabetesmellitus
AT hassalimohameda developmentandvalidationofqualityoflifescaleforiraqipatientswithtype2diabetesmellitus
AT hussainsaada developmentandvalidationofqualityoflifescaleforiraqipatientswithtype2diabetesmellitus
AT shawkynizar developmentandvalidationofqualityoflifescaleforiraqipatientswithtype2diabetesmellitus